Results 231 to 240 of about 1,620,706 (306)
This protocol paper outlines methods to establish the success of a time‐resolved serial crystallographic experiment, by means of statistical analysis of timepoint data in reciprocal space and models in real space. We show how to amplify the signal from excited states to visualise structural changes in successful experiments.
Jake Hill +4 more
wiley +1 more source
Protocol for high-content drug screening using tumor organoids on a 384-pillar plate platform. [PDF]
Choi JS, Lee MS, Song MJ, Jeong K.
europepmc +1 more source
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel +8 more
wiley +1 more source
Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening. [PDF]
Bouley SJ, Housden BE, Walker JA.
europepmc +1 more source
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu +10 more
wiley +1 more source
Development of a liquid overlay-based three-dimensional cell culture panel for drug screening applications. [PDF]
Depresle M +7 more
europepmc +1 more source
Despite frogs avoiding low temperatures, examination of four salamander species revealed that none avoided cold and all possessed cold tolerance. Functional analysis of TRPM8, a cold sensor, showed that all salamander TRPM8s had lost their cold sensitivity.
Tadahiro Sawao +3 more
wiley +1 more source
Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening. [PDF]
Qian J +8 more
europepmc +1 more source
Transcriptomics-guided high-throughput drug screening identifies potent therapies for P53 pathway altered DIPG/DMG. [PDF]
Jiang Z +10 more
europepmc +1 more source

